These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29944372)

  • 1. Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB.
    Cleghorn LAT; Ray PC; Odingo J; Kumar A; Wescott H; Korkegian A; Masquelin T; Lopez Moure A; Wilson C; Davis S; Huggett M; Turner P; Smith A; Epemolu O; Zuccotto F; Riley J; Scullion P; Shishikura Y; Ferguson L; Rullas J; Guijarro L; Read KD; Green SR; Hipskind P; Parish T; Wyatt PG
    J Med Chem; 2018 Aug; 61(15):6592-6608. PubMed ID: 29944372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
    Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration.
    van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K
    J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Borthwick JA; Alemparte C; Wall I; Whitehurst BC; Argyrou A; Burley G; de Dios-Anton P; Guijarro L; Monteiro MC; Ortega F; Suckling CJ; Pichel JC; Cacho M; Young RJ
    J Med Chem; 2020 Mar; 63(5):2557-2576. PubMed ID: 31922409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex.
    Murnane R; Zloh M; Tanna S; Allen R; Santana-Gomez F; Parish T; Brucoli F
    Bioorg Chem; 2023 Sep; 138():106659. PubMed ID: 37336104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional synthesis on thiophene-containing trisubstituted methanes (TRSMs) as inhibitors of M. tuberculosis and 3D-QSAR studies.
    Singh P; Saha T; Mishra P; Parai MK; Ireddy S; Lavanya Kumar M S; Krishna S; Kumar SK; Chaturvedi V; Sinha S; Siddiqi MI; Panda G
    SAR QSAR Environ Res; 2016 Nov; 27(11):911-937. PubMed ID: 27885861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG.
    Mori G; Chiarelli LR; Esposito M; Makarov V; Bellinzoni M; Hartkoorn RC; Degiacomi G; Boldrin F; Ekins S; de Jesus Lopes Ribeiro AL; Marino LB; Centárová I; Svetlíková Z; Blaško J; Kazakova E; Lepioshkin A; Barilone N; Zanoni G; Porta A; Fondi M; Fani R; Baulard AR; Mikušová K; Alzari PM; Manganelli R; de Carvalho LP; Riccardi G; Cole ST; Pasca MR
    Chem Biol; 2015 Jul; 22(7):917-27. PubMed ID: 26097035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisynthetic modifications of antitubercular lanostane triterpenoids from Ganoderma.
    Chinthanom P; Vichai V; Dokladda K; Sappan M; Thongpanchang C; Isaka M
    J Antibiot (Tokyo); 2021 Jul; 74(7):435-442. PubMed ID: 33981028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages.
    Pulipati L; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2649-54. PubMed ID: 27101894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 4-Amino-Thieno[2,3-
    Harrison GA; Mayer Bridwell AE; Singh M; Jayaraman K; Weiss LA; Kinsella RL; Aneke JS; Flentie K; Schene ME; Gaggioli M; Solomon SD; Wildman SA; Meyers MJ; Stallings CL
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31511370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G; Devi PB; Nallangi R; Sridevi JP; Saxena S; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Mar; 22(6):1938-47. PubMed ID: 24565972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
    Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
    PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and anti-tubercular evaluation of new 2-acylated and 2-alkylated amino-5-(4-(benzyloxy)phenyl)thiophene-3-carboxylic acid derivatives. Part 1.
    Lu X; Wan B; Franzblau SG; You Q
    Eur J Med Chem; 2011 Sep; 46(9):3551-63. PubMed ID: 21641695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the cytochrome bc
    Wani MA; Dhaked DK
    Mol Divers; 2022 Oct; 26(5):2949-2965. PubMed ID: 34762234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents.
    Wu Y; Cheung CY; Zhou Y; Wang Z; Tu Z; Cook GM; Lu X
    Bioorg Med Chem; 2021 Nov; 49():116426. PubMed ID: 34624820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis.
    Wang F; Sambandan D; Halder R; Wang J; Batt SM; Weinrick B; Ahmad I; Yang P; Zhang Y; Kim J; Hassani M; Huszar S; Trefzer C; Ma Z; Kaneko T; Mdluli KE; Franzblau S; Chatterjee AK; Johnsson K; Mikusova K; Besra GS; Fütterer K; Robbins SH; Barnes SW; Walker JR; Jacobs WR; Schultz PG
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2510-7. PubMed ID: 23776209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.